SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 264.14 |
| Enterprise Value ($M) | 163.64 |
| Book Value ($M) | 541.22 |
| Book Value / Share | 9.28 |
| Price / Book | 0.49 |
| NCAV ($M) | 328.50 |
| NCAV / Share | 5.63 |
| Price / NCAV | 0.80 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.03 |
| Return on Assets (ROA) | -0.03 |
| Return on Equity (ROE) | -0.03 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 4.84 |
| Current Ratio | 4.85 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 432.39 |
| Assets | 645.12 |
| Liabilities | 103.89 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Renaissance Technologies Llc | 6.40 | 27.40 | |
| 13G/A | Vanguard Group Inc | 6.01 | -13.43 | |
| 13G/A | Dimensional Fund Advisors Lp | 3.40 | -31.04 | |
| 13G/A | BlackRock, Inc. | 14.50 | 23.48 | |
| 13G/A | State Street Corp | 2.13 | -67.06 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 94,322 | 420,711 | 22.42 | |
| 159,219 | 581,140 | 27.40 | |
| 108,466 | 505,029 | 21.48 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| URGN – UroGen Pharma Ltd. | VCEL – Vericel Corporation |
| VERA – Vera Therapeutics, Inc. | VRCA – Verrica Pharmaceuticals Inc. |
| WVE – Wave Life Sciences Ltd. |
Financial data and stock pages provided by
Fintel.io